| NDC Code | 33332-417-10 |
|---|
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (33332-417-10) > 5 mL in 1 VIAL, MULTI-DOSE (33332-417-11) |
|---|
| Product NDC | 33332-417 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Afluria Quadrivalent |
|---|
| Non-Proprietary Name | Influenza A Virus A/singapore/gp1908/2015 Ivr-180a (h1n1) Antigen (propiolactone Inactivated), Influenza A Virus A/hong Kong/4801/2014 X-263b (h3n2) Antigen (propiolactone Inactivated), Influenza B Virus B/brisbane/46/2015 Antigen (propiolactone Inactivated), And Influenza B Virus B/phuket/3073/2013 Bvr-1b Antigen (propiolactone Inactivated) |
|---|
| Dosage Form | INJECTION, SUSPENSION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20170816 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125254 |
|---|
| Manufacturer | Seqirus Pty Ltd |
|---|
| Substance Name | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180A (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/BRISBANE/46/2015 ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED) |
|---|
| Strength | 15; 15; 15; 15 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|